Get started
TopgOptions

ACRS Aclaris Therapeutics Potential Buyout

Long
Aclaris Therapeutics, Inc. (BATS:ACRS)  
TopgOptions  
BATS:ACRS   Aclaris Therapeutics, Inc.
Trend Analysis Technical Indicators Fundamental Analysis ACRS aclaris therapeutics aclaristherapeutics buyout rumors takeover stockstobuy buysignal
7
3
trendanalysis indicator fundamental acrs aclaris therapeutics aclaristherapeutics buyout rumors takeover stockstobuy buysignal
ACRS Aclaris Therapeutics has 3 clinical trials releasing topline data this year and sufficient cash to fund their operations through the end of 2025.

ACRS is in Piper Sandler`s potential 12 biotech takeovers in 2023.

ACRS reached 52 week low today: $5.05.

Analysts Price Targets:
$21 The Goldman Sachs Group
$29 BTIG Research
$38 Cantor Fitzgerald
$43 HC Wainwright

Considering the above, I think ACRS might be an easy +3X!

Looking forward to read your opinion about it.
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals www.patreon.com/PremiumOptionsSignals
RESULTS www.bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.